Encompass Health Corporation is a provider of inpatient rehabilitation services, operating a network of hospitals that offer specialized rehabilitative treatment for patients recovering from major injuries or illnesses. The company focuses on restoring functional ability and independence through intensive therapy, utilizing advanced technology and interdisciplinary clinical approaches. Its patient population primarily consists of individuals admitted from acute-care hospitals following physician referrals, with common conditions including strokes, hip fractures, and neurological disorders. The company operates in 39 states and Puerto Rico, with significant concentrations in Florida and Texas. Encompass Health maintains strategic relationships with major healthcare systems, with a substantial portion of its hospitals operating as joint ventures with acute-care facilities. The company also engages in post-acute care solutions, leveraging clinical expertise and data to improve patient outcomes and care coordination across the healthcare continuum.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Medical Care Facilities Homepage encompasshealth.com
Sector Healthcare IR page investor.encompasshealth.com
Tags
inpatient rehabilitation, stroke care, neurological rehabilitation, orthopedic rehabilitation, post-acute care, joint ventures, clinical protocols, patient outcomes, care coordination, healthcare systems
Press page —

Metrics

Valuation  
Market cap $ 11.921B
Market cap (USD) $ 11.921B
P/E 19.41
PEG 0.65
P/BV 4.45
P/S 1.88
P/OCF 9.14
P/FCF 26.07
Dividend yield 0.64%
Turnover / mcap —
Returns  
ROE 25.1%
ROI 11.5%
ROIC 17.0%
Profit margin 9.5%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 30.0%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 102.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 51
Quality score 27.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2001 FY 2000
Revenue 5.935B 5.373B 4.801B 4.349B 5.122B 4.644B 4.605B 4.277B — — — — — — — — — 1.842B 1.753B 3B 3.208B 3.754B 3.909B — —
Net profit 566.2M 455.7M 352M 271M 412.2M 284.2M 358.7M 292.3M 256.3M 247.6M 183.1M 222M 323.6M 185M 208.7M 899M 94.8M 252.4M 653.4M -625M -445.994M -174.47M -434.557M 202.387M 278.465M
Free cash flow 439.2M 360.3M 267.7M 141M 186.9M 308.7M 262.9M 507.9M 431.4M 427.8M 356.4M 274M 275.1M 270.7M 242.4M 260.1M 333.9M 171.2M 191.3M -219.6M -92.484M 235.424M 426.873M 230.362M 213.125M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2001 FY 2000
Share price 106.14 92.35 66.72 59.81 65.26 82.69 69.27 61.7 49.41 — — — — — — — — — — — — — — — —
Price performance 12m 0.15 0.38 0.12 -0.08 -0.21 0.19 0.12 0.25 — — — — — — — — — — — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 432M 460M 460M 499M 563M 667M 525M 600M 593M 613M
↳ YoY growth +5.2% +6.4% +0.1% +8.4% +12.9% +18.4% -21.3% +14.3% -1.1% +3.4%
↳ 5y CAGR +14.2% +13.0% +11.9% +9.1% +6.5% +9.1% +2.7% +5.5% +3.5% +1.7%
Borrowings, current (USD) 37.1M 32.3M 35.8M 39.3M 38.3M 42.8M 25.2M 24.8M 139M 43.6M
Borrowings, non-current (USD) 2.98B 2.55B 2.48B 3.02B 3.25B 3.24B 2.74B 2.69B 2.36B 2.45B
Lease liabilities (USD) — — 0.00 668M 646M 638M 585M 560M 534M 518M
Cash and deposits (USD) 40.5M 54.4M 69.2M 94.8M 224M 54.8M 21.8M 69.1M 85.4M 72.2M
Intangible assets (USD) 411M 403M 443M 476M 431M 418M 282M 278M 298M 308M
Right-of-use assets (USD) — — 0.00 277M 246M 242M 213M 209M 204M 213M
Net debt (borrowings + leases - cash) (USD) 2.98B 2.52B 2.45B 3.64B 3.71B 3.87B 3.33B 3.2B 2.95B 2.94B
Cash flow detail
Operating cash flow (USD) 606M 657M 762M 635M 705M 716M 706M 851M 1B 1.18B
Purchases of property, plant and equipment (USD) -178M -226M -255M -372M -396M -529M -565M -583M -643M -736M
Purchases of intangible assets (USD) -25.2M -19.2M -16M -31.7M -12.2M -22.3M -19.3M — — —
Change in receivables (cash effect) (USD) -128M -83.9M 7M -22.9M -38.1M -64.3M -16.9M -22.4M 3M -15.2M
Change in payables (cash effect) (USD) 6.3M 7.5M 6.6M -6.1M 13.6M 14.9M 2.3M 11.8M 3M -22.6M
Dividends paid (cash effect) (USD) -83.8M -91.5M -101M -109M -112M -112M -99M -60.4M -62.8M -71.1M
Share buybacks (cash effect) (USD) -65.6M -38.1M 0.00 -45.9M -6.1M 0.00 0.00 0.00 -31.1M -158M
Interest paid (cash effect) (USD) -164M -151M -150M -156M -168M -168M -178M -148M -147M -133M
Income taxes paid (cash effect) (USD) -33.3M -96.4M -115M -104M -34.3M -131M -51.2M -109M -165M -124M
Share-based compensation (USD) 27.4M 47.7M 85.9M 114M 29.5M 32.8M 29.2M 50.6M 48.3M 56.5M
Operating cash flow before change in receivables (USD) 733M 741M 755M 658M 743M 780M 723M 873M 1,000M 1.19B
Free cash flow (OCF - PPE - intangibles) (USD) 403M 412M 492M 231M 297M 165M 122M 268M 360M 439M
Income detail
Total comprehensive income (USD) 318M 335M 375M 446M 369M 517M 366M 463M 597M 760M
Comprehensive income to owners (USD) 248M 256M 292M 359M 284M 412M 271M 352M 456M 567M
Provision for credit losses (USD) 61.2M 52.4M — — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 14.5% 11.8% — — — — — — — —
Reported Feb 22, 2017 Feb 28, 2018 May 1, 2019 Feb 27, 2020 Feb 26, 2021 Feb 25, 2022 Feb 27, 2023 Feb 28, 2025 Feb 28, 2025 Feb 26, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

BIRMINGHAM, Ala., and MELBOURNE, Fla., Nov. 6, 2026 — On Nov. 1-2, 2026, sustained torrential rains led to the flooding, evacuation and closure of Sea Pines Rehabilitation Hospital in Melbourne, Florida (“Sea Pines”). Sea Pines is a 90-bed hospital owned by a joint venture between Encompass Health and Holmes Regional Medical Center (a subsidiary of Health First). All patients were safely evacuated from Sea Pines and were either admitted to another appropriate medical facility or were discharged home. All Sea Pines employees have been accounted for. The flooding resulted in substantial damage to Sea Pines, and the hospital remains closed indefinitely. The joint venture is committed to reopening and continuing the operation of Sea Pines and is evaluating alternatives for refurbishing or replacing the hospital.

“We are enormously grateful for the heroic efforts of our hospital staff and the first responders in ensuring the safety of our patients during this catastrophic weather event,” said Pat Tuer, Encompass Health executive vice president and chief operating officer.

Sustainability

A letter from Mark Tarr Our Company About us

A letter from Mark Tarr PRESIDENT AND CHIEF EXECUTIVE OFFICER

Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving

As the nation’s largest provider of inpatient rehabilitation services, Encompass Health is dedicated to continuously improving our sustainability while providing the high-quality, compassionate care that makes us the trusted choice. We are driven by our purpose, which is at its core focused on sustaining our patients’ independence. Our purpose states, “We serve our patients and communities through customized rehabilitation that exceeds expectations. Our care teams are committed to achieving the best possible outcomes and getting our patients back to what matters most.” In other words, our goal is to treat our patients’ medical conditions so that they can resume their lives to the greatest extent possible. That is sustainability on an individual level. More patients and communities across the country need intensive rehabilitative care as the population continues to age. To meet those needs, we are expanding our capacity by building and maintaining a robust pipeline of new hospital projects, in many cases as joint ventures with acute care hospitals, and adding capacity to our existing hospitals. However, our sustainability story extends beyond the walls of our inpatient rehabilitation hospitals. We are also dedicated to supporting the communities in which we serve. Whether it be through strategic sponsorships, research grants or educational endowments, Encompass Health is partnering with a variety of worthy organizations and individuals to make a positive impact. In the following pages, you will learn more about our sustainability story. The story continues to unfold as these efforts grow and evolve, so visit our Patient Success Stories webpage to see the difference we are making in the lives of our patients.

Together to End Stroke United Way

Sustainability | 2

Our Company

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way

About us

As the nation’s leading inpatient rehabilitation provider, we deliver care that helps patients achieve life-changing results. Learn more in our Investor Reference Book.

173

Inpatient rehabilitation hospitals

67

Joint ventures

Our Approach

39

States & Puerto Rico

Data as of 2025 year-end

Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning

Inpatient Rehabilitation Hospitals Future Inpatient Rehabilitation Hospitals

Our Communities Charitable giving Together to End Stroke United Way

~42,300 employees

~263,300

patient discharges

~$5.9 billion revenue

Data as of 2025 year-end

Sustainability | 4

Board of directors

A letter from Mark Tarr Our Company About us

Our board is comprised of directors who represent a diverse set of experiences, expertise and perspectives. The board is almost entirely independent, with Mark Tarr (our president and CEO) being the only non-independent member. We have a beneficial mix of director tenures, which gives our board the benefit of fresh perspectives while maintaining experience, continuity and stability on our board. The board’s membership guidelines recognize that diversity of skills, perspectives and experiences promotes improved monitoring and evaluation of the business and management on behalf of the stockholders and produces more creative thinking and solutions.

Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance

Edward M. Christie III

Our commitment to quality

Skills and experience In evaluating the suitability of individual candidates for board membership, our board of directors considers relevant factors, including, but not limited to: a general understanding of Marketing / Brand Healthcare / Medical Governance Development marketing, finance, information technology and cybersecurity; corporate strategy and other Cain A. Hayes elements relevant to the operation of aexperience large publicly-traded company in today’s4 business Joan E. 6Herman 8 Skills and Skills and environment; senior leadership experience; an experience understanding of our business or a related Marketing / Brand background; Healthcare / Medical healthcare business; educational and professional character; and whether Governance the Marketing / Brand Healthcare / Medical Governance Financial / Accounting Legal / Compliance / Public Policy / Development Development candidate would satisfy the independence standards of the New York Stock Exchange. Risk Management Regulatory /

Quality initiatives

Skills and experience Skills and experience Skills and experience

Cybersecurity Environmental initiatives Supply chain operations Our Patients

Marketing / Brand Development

Marketing / Brand Marketing / Brand Development Development

Skills and experience Our People

4 4

88

4

Charitable giving 8

Technology /

/ Compliance / United Way Legal Cybersecurity Risk Management Technology / Cybersecurity

3 9

8

8 8

66 9

Healthcare / Medical Legal / Compliance / Technology / / / Legal /Technology Compliance Governance Risk Management Cybersecurity Risk Management Cybersecurity

Governance Public Policy / Human Capital Public Policy / Regulatory / Management Regulatory / Relations Government Government Relations 6

4

88

Governance

Legal / Compliance /

Cybersecurity

8 Risk Management

68

39

3

7 Stakeholder Relations

7

9

8

8

Legal / Compliance

/ Risk Management Financial /Technology Accounting Governance Cybersecurity /Technology Risk Management / Legal / Compliance /6

8

90%

Human Capital Management

8

8

Governance

9 6

6

93

3

Public Policy /

Human Capital

Capital Regulatory / / Legal /Human Compliance Management Management Government Relations Risk Management Human Capital Public Policy / Management 9 7 Regulatory / 9 Government Relations

7

7

Government Relations 9

Stakeholder Relations

Leslye 9 7 G. Katz 9

9 Independent 1 Not Independent

7

9 Independent

1 Not Independent

Kevin J.7O’Connor

Stakeholder Relations Public Policy / Regulatory Stakeholder/ Relations Government Relations 7

9 7

PublicPolicy Policy/Regulatory 9 9 Relations Technology Human Stakeholder Relations Legal / Compliance Public / Capital 8/ / Governance Governance Stakeholder Cybersecurity Management / Government Relations Risk Management Regulatory Technology // Human Capital Stakeholder Relations Legal / Compliance / 6 Public Policy / Relations 9 Government Cybersecurity Management 7 7 7 3Regulatory / Risk Management 69 Technology / Human Capital Stakeholder Relations Christopher Reidy Government Relations39 7 7 Cybersecurity Management Senior Leadership/ Public Company Financial Literacy Strategic Planning 9 9 7 7 310 10 Human Capital Stakeholder Relations 10 Public Policy / Management Regulatory / Human Capital StakeholderTenure Relations (Median) Age (Median) Government Relations Independence Independence Tenure (Median) Independence Age (Median) Tenure (Median) Age (Median) Management 7 7 Independence Tenure (median) Age 9

3

3

4

Healthcare / Medical Healthcare / Medical Financial / Accounting8 8

Financial / Accounting Our Communities

logy / ecurity

Financial / Accounting

Financial / Accounting

Succession Healthcare planning Financial / Accounting / Medical

al / Accounting

Healthcare / Medical

Marketing / Brand

4 Healthcare / Medical

Marketing / Brand Education Development Marketing / Brand Development Talent development

Together to End Stroke

8

4

Financial / Accounting Development Healthcare // Accounting Medical Financial

4

C.A.R.E. SkillsFund and experience

xperience Employee engagement

4

Skills and experience

Patient privacy

ing / Brand pment

Greg Carmichael

Nancy Schlichting

7 90%

7 years

2 <4 years 4 4-8 years < 4 years 4 >8 24years 4 – 8 years

9 Independent

4 > 8 years

1 Not Independent

7 64 years years

90%

4 50 – 60 years 9 Independent 2 < 43years 61 – 70 years 1 Not Independent 4 4 –38>years 70 years 4 > 8 years

64 7 years

years 4 50-60 years 3 61-70 years < 4 years 3 24>70 4years 50 – 60 years 4 – 8 years 3 61 – 70 years 4 > 8 years 3 > 70 years

64 years

Terrance Williams 4 50 – 60 years 3 61 – 70 years 3 > 70 years

Mark Tarr

Sustainability | 5

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach

The Encompass Health Way Encompass Health is a purpose-driven company. Our business provides real value to the communities and patients we serve. As our purpose states, “We serve our patients and communities through customized rehabilitation that exceeds expectations. Our care teams are committed to achieving the best possible outcomes and getting patients back to what matters most.​” To further embed our purpose, The Encompass Health Way, our core set of values, was created by our employees for our employees and provides:

Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Set the standard We are committed to going above and beyond, never settling for anything less than excellence. We pride ourselves on being industry leaders and challenge ourselves to continuously improve.

Lead with empathy We start with empathy, taking the time to understand the physical, mental and emotional needs of each other and those we support. We listen, make deep connections and engage on a personal level to better serve others.

Do what’s right We do the right thing the right way, no matter how difficult, even when no one is looking. We’re not afraid to have hard conversations. If we make a mistake, we acknowledge it, proactively find a resolution and make it right going forward.

Focus on the positive We have a positive spirit and find the light even in the most difficult situations. We bring our whole self to work. We celebrate successes and inspire others to create meaningful impact.

Stronger together We believe our individual strengths make us stronger together. We take accountability for our actions, connect across teams and lean in to get it done – at all levels of the Company.

Sustainability | 6

Our Approach

A letter from Mark Tarr Our Company About us Board of directors

Governance

We have long been committed to best practice corporate governance and have been repeatedly recognized for our corporate governance.

The Encompass Health Way

Stockholders may amend our bylaws by simple majority vote

Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives

Here are some of our corporate governance highlights:

Proxy reimbursement bylaw for stockholder proxy solicitation expenses

Independent, non-executive chairman of the board

Stockholders may act by written consent

Heightened board independence requirement (75% must be independent; currently 90% are)

Stockholders representing 20% of outstanding shares may call a special meeting

Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities

Independent sessions are scheduled at every regular meeting of our board and its committees Robust stock ownership requirements for directors and officers

Term limit for directors of 15 years, subject to exceptions at the board’s discretion Mandatory retirement age for directors of 75, subject to exceptions at the board’s discretion

Charitable giving Together to End Stroke

No poison pill in place

Limitations on directorships for executive officers

Declassified board

Enterprise risk management, including cybersecurity, and ESG oversight by full board and designated committees on regular schedule

United Way

Single class of voting stock

Sustainability | 8

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations

Ethics & compliance Encompass Health has a comprehensive ethics and compliance program based on the “Seven Elements of an Effective Compliance Program,” that government regulators deem necessary to demonstrate a culture that encourages ethical conduct and a commitment to compliance with legal requirements. The program employs an ongoing awareness model and risk management framework to promote compliance and appropriate standards of business conduct. It is administered by the Chief Compliance Officer (CCO) with guidance and support of an executive compliance committee and has been embedded into every level of company operations.

“We embrace the Standards of Ethics and Business Conduct as the foundation of our corporate culture, which is based on honesty, openness and integrity. Our shared commitment to these core principles is the cornerstone of a strong Encompass Health.” — Dawn Rock, Chief Compliance Officer

Our commitment to quality

The program empowers employees and other stakeholders to work in a legal and ethical manner by providing the necessary tools, oversight and guidance to foster compliance with legal requirements, support ethical business decision making and promote a “speak-up” culture. These include:

Quality initiatives

• Mandatory compliance training annually

Our Patients

Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

• Open lines of communication, including a hotline administered by a third-party vendor that allows for anonymous reporting 24 hours a day, seven days a week • A code of conduct, compliance policies and other written materials that provide practical guidance on compliance obligations and expectations • Open and unfettered access to the CCO, privacy officer, general counsel, Inspector General (IG) and other key leaders to ask questions about compliance obligations or report suspected noncompliance In addition, to continuously monitor various operational functions, we use independent audits, data mining and analytics, risk assessments, ongoing performance evaluation, trending and other risk identification techniques. We promptly address audit or survey findings that fall below target thresholds and substantiated allegations of noncompliance. We track the resulting corrective actions to completion and, as appropriate, we retest at a later date to verify effectiveness of remedial efforts. Our board of directors and its committees maintain direct lines of communication with our executives overseeing compliance matters. The Compliance and Quality of Care Committee of the board appoints and oversees our CCO and receives direct reports from the CCO, the Chief Information Officer and the Chief Medical Officer. The Audit Committee appoints and oversees our IG, who leads our internal audit department, and receives direct reports from the IG quarterly. Standards of Ethics and Business Conduct

Sustainability | 9

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Cybersecurity The proper function, availability and security of our internal and third-party information systems are critical to our business. We recognize the growing cyber threat to the healthcare industry and have attempted to structure our cybersecurity program and its incident response policies and procedures around the National Institute of Standards and Technology Cybersecurity Framework, which provides best practices to identify, protect from, respond to and recover from cyber attacks. The cybersecurity program, led by our chief security officer (“CSO”), consists of dedicated internal IT security employees, including the staff of a security operations center and long-term third-party security service providers. The CSO reports directly to our Chief Information Officer (“CIO”). Our CIO provides quarterly detailed reports, including cyber-hygiene measures, on our cybersecurity program to the Board’s Compliance and Quality of Care Committee and at least annually to our full board of directors. We also maintain an inter-departmental privacy and security committee that meets at least monthly and oversees our programs and initiatives that seek to protect and secure our data and systems. For example, this committee is responsible for our annual ITSecurity Incident Response Plan and various training and awareness programs that promote good patient privacy and system security practices by employees.

Cybersecurity program As part of an aggressive cybersecurity program, we continually evaluate and test the tactics, techniques and processes used by “bad actors” to adequately prepare and provide a secure and trusted environment for our patients, clinicians, employees and other stakeholders. Our external risk assessment process includes: • Cybersecurity maturity reviews • Penetration tests • External dependencies management assessments • Incident response exercises • Continuous internet perimeter vulnerability scanning • Industry and expert security collaboration on current and emerging threats • Annual significant vendor risk assessments • Ongoing engagement with industry and governmental cybersecurity cooperative groups, including the Health Information Sharing and Analysis Center and the FBI’s InfraGard, to identify and combat known and emerging threats We practice resilience on a routine basis through: • Multi-disciplinary participation in an annual incident response plan exercise • Quarterly disaster recovery exercises • Annual corporate business continuity exercise • External parties perform disinterested cybersecurity penetration tests and risk assessments • Continual security awareness training for all employees, including quarterly email phishing exercises • Continual advancements of tools and techniques to protect and defend our environment with a focus on vulnerability discovery, patching and mitigation

Sustainability | 10

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Environmental initiatives Our greatest contribution to sustainability is the nature of our services. We provide high-quality, cost-effective patient care to the communities we serve. Our inpatient rehabilitation hospitals are substantially smaller than the typical acute care hospital and consume fewer resources. Our hospitals, allow for the transfer of patients not prepared to go home, transfers patients from higher-cost, more resource-intense facilities to lower-cost settings. Further, a significant percentage of our patients go home, not to another facility. Not only is the preferred outcome for our patients, but it also reduces the total cost of healthcare and the burden on the healthcare system. We undertake various recycling and energy conservation efforts. Current initiatives include recycling of non-medical waste and sharps containers, replacement of interior and exterior lighting in our hospitals with LED fixtures and migrating to energy-efficient HVAC equipment. We also trend and benchmark energy utilization by hospital and region on a quarterly basis to identify significant energy usage outliers.

Home Office

Building materials • Prefabrication technology is reducing construction waste by cutting material scrap and minimizing on site labor hours, and we are deploying it across everything from full hospital builds and bed additions to bathrooms and headwalls. • We are launching a solar panel pilot at up to four hospitals to advance renewable energy use and lower long term operating costs. • Standard paint has zero volatile organic compounds and is Greenguard certified. • Vinyl and porcelain tile and wall coverings include recycled content and are recyclable. LED Lighting • LED lighting is installed in all new hospitals in order to reduce energy consumption and maintenance costs. A program to upgrade all facility lighting at our hospitals began in 2019 with only a few upgrades yet to be completed. Waste Recycling • We have national pharmaceutical, medical and universal waste programs to ensure these materials are disposed of properly and their containers are recycled. • 80% of our hospitals utilize reusable sharps collection containers.

• Walking trail surface of slate rock, a

Our home office incorporates building design and environmental initiatives that include: • Intelligent lighting controls with occupancy sensors natural and sustainable material • Native plants and tree placement to minimize heat gain in summer and block winds in the winter • Centralized printing stations that default to two-sided paper printing • Plastic and aluminum container recycling

Sustainability | 11

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance

Supply chain operations Supply Chain Operations integrates best-in-class business practices to build a sustainable and resilient supply chain. These goals are accomplished through: •

Our purchasing supply chain technology system monitors our suppliers’ invoice pricing compared to underlying contracts and confirm necessary corrections.

•

Our process of soliciting feedback from our hospitals on our top 70 vendors includes an annual satisfaction survey on service levels, product quality and other metrics. Corrective action is taken for poor performance. We also have an internal digital tool that any employee can utilize to submit a concern about a national supplier. Supply chain staff reviews all concerns submitted.

•

Our group purchasing organization benchmarks our supply chain contracts with competing suppliers to ensure we are maximizing our purchasing leverage.

•

Our clinical committees routinely evaluate our patient care products and services for clinical best practices and desired outcomes.

•

Our data analytics processes provide energy utilization data to our hospitals for benchmarking and to identify potential opportunities to improve efficiencies.

•

Our resiliency program has transformed how we safeguard supplies, equipment, and service delivery across our hospitals. We created a reserve warehouse strategy, secured secondary supply agreements, and proactively substituted more than 700 critical products to stay ahead of disruption and introduced real time disruption alerts. The result is a smarter, faster, more dependable supply chain that keeps our hospitals equipped and ready to deliver exceptional care.

Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Our purchasing system identifies sustainable products via an icon. Vendors must meet at least one of the following criteria to be considered sustainable:

  1. Biodegradable
  2. Certified sustainable
  3. Compostable
  4. Energy conservation
  5. Green cleaning
  6. Product-recycled content
  7. Raw material reclamation
  8. Third-party certified
  9. USDA organic

Learn more about how we’re ensuring compliance with all of our vendors

Sustainability | 12

Our Patients

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance

Our commitment to quality We are proud of our track-record of providing quality care, as benchmarked against national industry standards. Our patients consistently achieve higher functional gains compared to the national risk-adjusted data. All our hospitals are certified by The Joint Commission. Additionally, our hospitals participate in The Joint Commission’s Disease-Specific Care Certification program, with 149 of our hospitals holding one or more Disease-Specific Certifications, including 148 hospitals with stroke-specific certifications. Our stroke rehabilitation certifications represent more than 60% of all stroke rehabilitation certifications issued by The Joint Commission. Other Disease-Specific Care Certifications include hip fracture, brain injury, amputee, Parkinson’s disease rehabilitation and more.

Ethics & compliance Cybersecurity Environmental initiatives

Discharge to Community

Supply chain operations Our Patients

higher is better

Our commitment to quality

82.7%

Our People C.A.R.E. Fund

9.1%

82.0%

6.6%

lower is better

8.8%

83.6% 81.1%

Discharge to Acute Care

lower is better

84.6%

Quality initiatives Patient privacy

Discharge to SNF

6.5%

8.3%

9.8%

9.7% 9.3%

6.1%

9.1% 8.9%

80.3%

8.6%

Education Talent development Employee engagement Succession planning Our Communities

2023

2024

2025

Percent of patients discharged to the community, including home or home with home health

2023

2024

2025

Percent of patients discharged to a skilled nursing facility

2023

2024

2025

Percent of patients discharged to an acute care hospital

Charitable giving Together to End Stroke United Way

Encompass Health

UDSMR

The above UDSMR measures include IRF units that are located within acute care hospitals.

Sustainability | 14

A letter from Mark Tarr Our Company

Quality initiatives

About us

Some examples of clinical initiatives we have to further improve quality include:

Board of directors

• Reduce Acute Care Transfers (known as ReACT) – To improve patient outcomes and reduce healthcare expenditures and penalties, we use our extensive proprietary database of inpatient rehabilitation patient records to develop a predictive model in 2015 to identify patients at risk of an acute care transfer and implement intervention strategies as part of the plan of care. In 2022, we updated the model by expanding the input variables and volume of data used to identify factors that might contribute to a patient needing to be acutely transferred, allowing our clinical teams to apply intervention strategies as part of the plan of care for the patient.

The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

• Pain control and reducing the use of opioids – We do not employ physicians, so we have no control over the prescription process. However, we have a multidisciplinary approach to improve pain management, including educating our clinicians on nonpharmacologic treatment of pain and vigilant opioid stewardship. • Infection control – Working with a contracted infection control expert, we have standardized and improved our infection control practices across the Company in order to reduce the risk of infection to patients and apply evidenced-based decision making to prevent the spread of infections. We developed a white paper that describes an approach to preventing infections that maximizes patient safety, promotes optimal clinical outcomes, increases patient satisfaction and avoids unnecessary limitations on participation in therapy. We presented this white paper at the national conferences for the Association for Professionals of Infection Control and the American Congress of Rehabilitation Medicine. • Patient falls – In response to the Institute of Medicine’s report “To Err is Human,” Congress developed the Patient Safety and Quality Improvement Act of 2005. This Act authorized the creation of Patient Safety Organizations for improving quality and safety by reducing the incidence of events that adversely affect patients. In 2016, we developed the Encompass Health Patient Safety Organization and obtained the applicable certification as a Patient Safety Organization from the Agency for Healthcare Research and Quality of the Department of Health and Human Services. In 2022, we implemented the Fall Prevention Program using a predictive analytics model with an interdisciplinary approach to individualized fall prevention. Since implementation, our fall rate per 1,000 patient days has decreased by approximately 32%. • Nutrition – We have developed an early intervention malnutrition screening tool that prompts nurses to start the correct supplement to meet the patient’s nutritional needs based on diet and diagnosis. We implemented food service management technology that provides our hospitals with an electronic meal ordering and preparation system with standardized menu options based on dietary requirements. The system also integrates with our EMR system to provide accurate and timely updates to diet requirements. • In-house hemodialysis program – Patients receiving dialysis treatments historically received their treatment through third-party vendors either onsite or offsite. In 2022, we began the rollout of providing onsite dialysis to our patients through the Tablo hemodialysis system. A patient is treated in an onsite dialysis suite staffed by a nephrologist and RNs with previous dialysis experience. The benefits to our patients include a better coordination of therapy and dialysis treatments, recovery time is shorter compared to traditional hemodialysis, and the hospital’s clinical team can take a complete holistic approach to the patient’s care plan. Sustainability | 15

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach

Patient privacy Our Company is subject to the Health Insurance Portability and Accountability Act of 1996, commonly known as HIPAA. We spend a significant amount of time and expense protecting the privacy of our patients, and our board of directors and its Compliance and Quality of Care Committee receive regular reports on our privacy and security compliance program. The privacy program is designed to foster a culture of privacy compliance that demonstrates our commitment to appropriately safeguarding the privacy of individuals’ protected health information (PHI).

Governance

The goals of the privacy program are to:

Ethics & compliance

• Establish policies and procedures to ensure compliance with all applicable federal and state privacy-related laws and regulations

Cybersecurity

• Outline institutional privacy and compliance roles

Environmental initiatives

• Conduct audits and otherwise proactively identify risks to patient PHI

Supply chain operations

• Provide education and training

Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

• Establish other mechanisms to implement the privacy program The privacy program is managed and overseen by a privacy officer in our compliance department with guidance from the privacy and security committee and the executive compliance committee. Each hospital has an assigned employee who acts as a hospital HIPAA officer (HHO). The HHO’s role is to coordinate the privacy function at the hospital level and act as a liaison between the privacy officer and the hospital. Privacy requirements and expectations are spelled out in our HIPAA Policy and Procedure Manual, which is accessible to all employees on our intranet. We ask all employees to complete detailed training on what constitutes PHI and procedures for the appropriate collection, usage, retention, disclosure and destruction of PHI within 30 days of hire and annually thereafter. We employ both physical and electronic safeguards to protect PHI, including card-only access to certain areas, encrypted electronic transmissions, required quarterly system access reviews, electronic auditing functions to help identify inappropriate system access and centralized mobile device management. We require a Business Associate Agreement when entering into agreements with companies that handle, use, distribute or access patient PHI. Our compliance department maintains and publicizes a telephone line and email address that may be used to report possible violations of these and other HIPAA requirements or our privacy policies or standard practices. The privacy officer and, if warranted, additional staff from across departments such as legal and IT investigate all possible data breaches. They perform root cause analyses on all substantiated breaches, taking appropriate actions to mitigate consequences of an existing breach while also applying safeguards to prevent future failures. They also monitor breach activity and report to the Privacy and Security Committee, Executive Compliance Committee and the Compliance and Quality of Care Committee of our board of directors. A thirdparty advisor conducts an annual security simulation exercise where we test and prepare for our responses to cybersecurity and privacy breach-related matters. Sustainability | 16

Our People

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach

The C.A.R.E. Fund is an employee-inspired initiative as a means for Encompass Health employees to assist their colleagues in the

Governance

face of adversity. The fund is an example of our values in action, leading with empathy by caring for one another and uniting for a

Ethics & compliance

cause because we are stronger together.

Cybersecurity Environmental initiatives

The C.A.R.E. Fund has made a lasting impact on the lives of employees and their families who are affected by the aftermath of

Supply chain operations

covered natural disasters, ranging from hurricanes and tornadoes to earthquakes, floods and winter storms. Since inception, the

Our Patients

C.A.R.E. Fund has provided assistance to more than 1,400 Encompass Health employees during unanticipated times of need.

Our commitment to quality Quality initiatives

Donations can be made by employees as a one-time donation or through payroll deduction. Encompass Health is proud to match

Patient privacy

employee donations given to the C.A.R.E. Fund dollar for dollar. Donations are used to help employees with temporary lodging,

Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities

food, transportation and supplies.

Support provided to 885 employees from 2021 to 2025 2021 Winter Storm TX

Charitable giving Together to End Stroke

2022

2023

Hurricane Fiona

Tornados TN/AR

Hurricane Ian

Hurricane Idalia

89 employees

22 employees

United Way

70 employees

2024

2025

Severe Weather TX/AR/OK

Severe Weather TX

Hurricanes Beryl, Debby, Helene & Milton

Tornados AR/MO

695 employees

9 employees Sustainability | 18

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Education Through grant and scholarship opportunities, we are committed to assisting future healthcare employees and funding important research to benefit our patients. Some of those opportunities include: Encompass Health and Chamberlain University Encompass Health teamed up with Chamberlain University to offer our nurses an opportunity to seek higher education at a reduced rate. Through the partnership, nurses can advance their degrees at a tuition rate of 30 to 50 percent of the total program cost, depending on the program, which includes a registered nurse with an associate’s degree to bachelor of science in nursing degree, master of science in nursing degree, doctor of nursing practice degree and other graduate and post baccalaureate certificates. Tuition reimbursement/scholarship programs Employees have the opportunity to advance their education through Encompass Health’s tuition reimbursement and scholarship programs. In 2025, Encompass Health contributed ~$1.3 million in tuition reimbursement for eligible employees. Student loan repayment In 2025, Encompass Health paid ~$4.5 million toward student loan repayment for eligible employees. Academic donations and partnerships Encompass Health makes financial contributions to support and inspire students to serve others in the health profession, in turn positively influencing healthcare and society. In 2025, the Company contributed to: • • • • •

The University of Alabama at Birmingham The University of Alabama Samford University Auburn University Foundation University of Kentucky

“Samford revitalized my life. What this scholarship stands for is the most important thing to me.” HANS RICE, SAMFORD UNIVERSITY

“ I am very grateful and thankful … Because of your scholarship, I am one step closer to graduating.” NATASHIA FANNING, TUSKEGEE UNIVERSITY “Thank you … This scholarship has directly impacted my family.” ERIC GONZALEZ DIAZ, SAMFORD UNIVERSITY

“Thank you for supporting me … and allowing me to continue my dreams. Your generosity truly makes a difference.” NINA BATTLE, TUSKEGEE UNIVERSITY “ I really have a heart for missions, and I love getting to do service learning projects as part of my curriculum.” JOY DEES, SAMFORD UNIVERSITY

In addition to our financial contribution to support students in healthcare professions, our hospitals serve as clinical rotation sites for more than 300 schools. We are providing students with real-world, tangible workforce experience and developing the future inpatient rehabilitation workforce.

Encompass Health therapy grants Each year, the Company awards grants to fund research projects aimed at the investigation of the impact and effectiveness of therapy in the inpatient rehabilitation setting. In recent years, grants have been awarded to fund studies and research on topics ranging from caregiver education to the effectiveness of occupation-centered interventions. The program is open to employees, as well as other qualified candidates offering research projects aimed at improving rehabilitation in post-acute care.

Sustainability | 19

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach

Talent development Developing talent internally and attracting top talent is an integral part of our recruitment and retention strategies. We recruit from top professional organizations across the country as a way to source talent with diverse experiences and backgrounds. We have identified top colleges for nursing, therapy and healthcare administration to recruit candidates. We have also implemented programs to develop future hospital chief executive officers and chief nursing officers, which are two of the most critical positions in our hospitals. These programs provide an experiential and hands-on development opportunity for internal and external candidates to fill these critical positions.

Governance

Employee development programs include but are not limited to:

Ethics & compliance

• Career Ladders – Programs designed to recognize and reward eligible staff members for expanding their skill sets, clinical knowledge, and leadership responsibilities within nursing, therapy, case management and pharmacy. Career ladders play an important role in supporting recruitment and retention by providing meaningful advancement pathways. Participation continues to increase as clinicians pursue opportunities to grow professionally while contributing to improved patient outcomes.

Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

• Online Development Library – Access to a wide range of readily available internal and external content on many topics important for success in current or desired jobs. The library includes our Clinical Excellence University series of inpatient rehabilitation specific educational offerings taught by expert Encompass Health clinicians. • Developing Future Leaders – Developing Future Leaders (DFL) is a two-year program designed to accelerate the development of full-time employees in good standing who aspire to grow into management. The program has three levels: Aspire to Supervisor, Aspire to Manager and Aspire to Director. This program provides a developmental road map to follow with your manager’s support, giving participants an opportunity to develop their qualifications for management roles. • Leadership Precepting – Provides new leaders six to 12 months of structured mentoring from experienced, high-performing peers • Leadership Coaching – The purpose of Leadership Coaching is to accelerate the development of key talent. We do this by supporting and coaching the employee through the creation and implementation of a structured development plan to address development needs mutually agreed upon by the employee and manager. The goal of Leadership Coaching is for the employee to experience growth that may come in the form of positive change in behavior or insight into their own leadership. Since its inception, our Leadership Coaching Program has developed 120+ coaches which have in turn coached 900+ employees across Encompass Health. • Developing Future Chief Executive Officers – Designed to rapidly accelerate the development of candidates who aspire to become a hospital CEO, our 18 to 24 months Developing Future CEOs (DFCEO) program provides hands-on training and mentorship for emerging leaders. Candidates develop the skills needed to lead improvements in the hospital’s clinical, financial, employee and patient satisfaction outcomes. • Originated in 2013 with 4 participants • 54 placements to the CEO role since inception Our latest workplace demographic data from the EEO-1 Report can be found here. Sustainability | 20

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way

Employee engagement Encompass Health’s 2025 Employee Engagement Survey provides valuable insight into employee perceptions, enabling us to reinforce strengths and prioritize actions that enhance engagement. In 2025, our results outperformed both healthcare industry and rehabilitation benchmarks in every engagement category.

Encompass Health

Our Approach Governance Ethics & compliance Cybersecurity

Culture of Trust | 79.3% Culture of Safety | 86.2%

Healthcare

Rehabilitation 68.1%

69.5%

71.4%

72.7%

Environmental initiatives

Work Environment | 81.0%

68.3%

Supply chain operations

Teamwork | 83.7%

66.8%

67.8%

Leadership | 78.2%

66.1%

67.3%

Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development

Ethics & Compliance | 86.1% Individual Value | 77.7%

75.1% 71.6%

Inclusion & Diversity | 84.5% Engagement | 84.2% Communication | 76.3%

69.9%

76.6% 72.9%

73.2% 70.3% 65.7%

74.7% 73.2%

66.7%

Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Sustainability | 21

A letter from Mark Tarr Our Company About us Board of directors

Employee engagement When broken down by any race, age or gender category, every group scores above both the healthcare and rehabilitation average in the questions that indicate a work environment ripe for innovation.

The Encompass Health Way Our Approach

86.2% OF OUR EMPLOYEES SAID:

74.7% OF OUR EMPLOYEES SAID:

Governance

I have the resources (equipment, supplies, technology) needed to do my job.

There is effective collaboration across teams.

Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients

COMPARED TO:

COMPARED TO:

76.6% rehabilitation average 75.2% healthcare average

60.7% rehabilitation average 60.3% healthcare average

Our commitment to quality Quality initiatives Patient privacy

87.7% OF OUR EMPLOYEES SAID: I can depend on members of my team.

Our People

81.6% OF OUR EMPLOYEES SAID: Senior leaders/hospital senior management team is accessible to all employees.

C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

COMPARED TO:

61.3% rehabilitation average 60.8% healthcare average

COMPARED TO:

62.3% rehabilitation average 61.7% healthcare average

Why inpatient rehabilitation When looking at national benchmarks, rehabilitation hospitals outscore healthcare overall averages in 97% of measured items. In the other 3%, rehabilitation hospital scores were equal to healthcare overall. Below summarizes the categories rehabilitation hospitals excel in: • visible, caring and values driven leadership

• collaboration, teamwork and trust

• clear communication and transparency

• work life flexibility and well being

• strong manager effectiveness and support

• employee voice, inclusion and belonging

• resources and support for high quality patient care

• engagement, pride and intent to stay

• recognition and appreciation of employees

• ethical culture and psychological safety

• career development and growth opportunities Sustainability | 22

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach Governance Ethics & compliance

Succession planning We annually review our talent to identify potential successors for key positions and candidates for accelerated development based on their performance and potential. This process supports business continuity during management transitions. It includes an assessment of each employee’s promotability based on a set of leadership core competencies defined as part of the Company’s talent strategy. There are times we have to hire externally, but we look to promote within when possible.

Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education

In addition to executive and management succession, the Nominating/Corporate Governance Committee regularly oversees and plans for director succession and refreshment of our board of directors to ensure a diverse mix of perspectives, skills, experiences and tenures that promote and support our long-term strategy. In connection with long-term succession planning, the Nominating/Corporate Governance Committee engages, from time to time, a search firm to identify director candidates for our board in anticipation of replacing the directors who are approaching the tenure limits set forth in our Corporate Governance Guidelines.

Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Sustainability | 23

Our Communities

A letter from Mark Tarr Our Company

Charitable giving

About us

Encompass Health is committed to making a difference in the

Board of directors

communities it serves by providing financial and volunteer support to non-profit organizations in local communities. Our Home Office, as well as our individual locations, focus charitable giving in the following four areas:

The Encompass Health Way Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund

• Rehabilitation-related healthcare: Charities that focus on providing information, research or treatment in the healthcare arena, with special consideration given to organizations conducting physical rehabilitation research and patient support

Each year, we give nearly

$2 million

• Human services: Charities that focus on supporting human service organizations, particularly ones that improve the lives of those who are at risk or are facing unique challenges • Education: Charities that are committed to education as a means of helping young people prepare for the future with special consideration given to schools serving low- or moderate-income communities. Also included in this focus area are higher education initiatives and training programs, particularly those relevant to the healthcare industry. Organizations that focus on creating and maintaining an environment that fosters and promotes opportunities for higher education in minority communities. • Art and culture: Encompass Health believes art and culture make life more vibrant for everyone.

Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

In addition to monetary donations, our hospitals also routinely take part in fundraisers and local charity events.

Sustainability | 25

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way Our Approach

Together to End Stroke In 2019, Encompass Health became a national supporter of the American Stroke Association (ASA) and its Together to End Stroke campaign. Research from the ASA’s Guidelines for Adult Stroke Rehabilitation and Recovery shows that of the approximately 795,000 patients who have a stroke each year, two-thirds will require rehabilitation. That’s why we’re working together to show that stroke is treatable, beatable and preventable. Encompass Health treated more than 47,000 stroke patients in 2025 with an opportunity to continue to increase our market share.

Governance

A GUIDE FOR PATIE AND CAREGIVERS

Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations

LIFE AFTER STROKE Our Path Forward

Our Patients

NTS

GUÍA PAR A PACIEN TES Y CUIDADO RES

LA V UN ATAQ IDA TRAS UE CEREB Nuestro ca

mino hacia

Our commitment to quality

delante

RAL

In 2025, more than 7.5% of patients recovering from a stroke in the U.S. were treated at our hospitals, accounting for approximately 18% of our overall patient mix.

Quality initiatives Patient privacy Our People

is a national sponsor Encompass Health Stroke. of Together to End

C.A.R.E. Fund Education

Encompass Health es un patroc nacional inador de Togeth er to End Stroke.

Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Co-branded educational materials Through our continued collaboration, we have strengthened our support of stroke survivors, caregivers, and their families. In 2025, we added two additional evidence-based tools to the American Heart Association library, Dysphagia After Stroke lesson module and Fall Prevention Toolkit. Our modules have been promoted at various conferences with more than 4.1 million video views. Our co-developed Stroke Prevention Toolkit, Life After Stroke Guide and Simply Good cookbook are also available. Learn more here.

Local community outreach Encompass Health staff are actively engaging with their local AHA/ASA chapters by serving on volunteer committees, local board of directors and more. Our sponsorship of the AHA’s “Go Red for Women” luncheons allows us to educate our communities about the warning signs of stroke and the deficits a stroke patient may face.

Sustainability | 26

A letter from Mark Tarr Our Company About us Board of directors The Encompass Health Way

Supporting our Central Alabama community •

82% of Home Office staff participated in our 2025 United Way fundraising campaign, raising $763,802

•

Encompass Health’s Home Office is proud to sponsor a Habitat for Humanity home build to advance affordable home ownership in the Birmingham area. Our employees support the project by contributing their time and talents.

Our Approach Governance Ethics & compliance Cybersecurity Environmental initiatives Supply chain operations Our Patients Our commitment to quality Quality initiatives Patient privacy Our People C.A.R.E. Fund Education Talent development Employee engagement Succession planning Our Communities Charitable giving Together to End Stroke United Way

Sustainability | 27

This is only part of sustainability at Encompass Health. Learn more about the people and the stories that are helping sustain Encompass Health and its patients, people and communities for generations to come.

News Release

Encompass Health reports results for third quarter 2026 2026-10-28

Increases full-year guidance BIRMINGHAM, Ala., Oct. 28, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2026.

Summary results

Q3 2026 Net operating revenue Income from continuing operations attributable to Encompass Health per diluted share Adjusted earnings per share Cash flows provided by operating activities Adjusted EBITDA Adjusted free cash flow (Actual Amounts) Discharges Same-store discharge growth Net patient revenue per discharge

$

$

1,609.5

Q3 2025

Growth

(In Millions, Except Per Share Data) $ 1,477.5 $ 132.0

1.51 1.52 362.0 346.6 263.4

1.24 1.23 270.8 300.1 174.2

69,605

65,839

22,543

Dollars

$

Percent

0.27 0.29 91.2 46.5 89.2

21,679

8.9 % 21.8 % 23.6 % 33.7 % 15.5 % 51.2 % 5.7 % 3.0 % 4.0 %

See attached supplemental information for calculations of non-GAAP measures and reconciliations to their most comparable GAAP measure. "We are very pleased with our performance for the third quarter, with revenue increasing 8.9% and Adjusted EBITDA growing 15.5%," said Mark Tarr, President and Chief Executive O cer. "During the rst nine months of 2026, we opened four hospitals totaling 189 beds and added 85 beds to existing hospitals, re ecting our commitment to meeting the growing demand for high-quality inpatient rehabilitation services. Our value proposition and disciplined operating strategy continue to be validated, and we remain highly optimistic about the long-term prospects of our business."

2026 Guidance 1

The Company increased its full-year guidance as follows:

Full-Year 2026 Guidance

Net operating revenue Adjusted EBITDA Adjusted earnings per share from continuing operations attributable to Encompass Health

Previous Guidance Updated Guidance (In Millions, Except Per Share Data) $6,410 to $6,490 $6,450 to $6,500 $1,365 to $1,395 $1,395 to $1,415 $6.02 to $6.25

$6.23 to $6.37

For considerations regarding the Company's 2026 guidance, see the supplemental information posted on the Company's website at http://investor.encompasshealth.com. See also the "Other information" section below for an explanation of why the Company does not provide guidance for comparable GAAP measures for Adjusted EBITDA and adjusted earnings per share.

Earnings conference call and webcast The Company will host an investor conference call at 10:00 a.m. Eastern Time on Thursday, October 29, 2026 to discuss its results for the third quarter of 2026. For reference during the call, the Company will post certain supplemental information at http://investor.encompasshealth.com. The conference call may be accessed by dialing 833 354-6854 and giving the conference ID EHCQ326. International callers should dial 785 838-9343 and give the same conference ID. Please call approximately ten minutes before the start of the call to ensure you are connected. The conference call will also be webcast live and will be available for on-line replay at http://investor.encompasshealth.com by clicking on an available link.

About Encompass Health Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 179 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized by Newsweek as America's Most Awarded Leader in Inpatient Rehabilitation and is ranked among Fortune's World's Most Admired Companies™[1] and Forbes' America's Best Companies. It is also recognized by Becker's Healthcare and Modern Healthcare as a top healthcare employer. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.


1 From Fortune. © 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired

Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.

Other information 2

The information in this press release is summarized and should be read in conjunction with the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 (the "September 2026 Form 10-Q"), when led, as well as the Company's Current Report on Form 8-K led on October 28, 2026 (the "Q3 Earnings Form 8-K"), to which this press release is attached as Exhibit 99.1. In addition, the Company will post supplemental information today on its website at http://investor.encompasshealth.com for reference during its October 29, 2026 earnings call. The nancial data contained in the press release and supplemental information include non-GAAP nancial measures, including the Company's adjusted earnings per share, leverage ratio, Adjusted EBITDA, and adjusted free cash ow. Reconciliations to their most comparable GAAP measure, except with regard to non-GAAP guidance, are included below or in the Q3 Earnings Form 8-K. Readers are encouraged to review the "Note Regarding Presentation of Non-GAAP Financial Measures" included in the Q3 Earnings Form 8-K which provides further explanation and disclosure regarding the Company's use of these non-GAAP nancial measures. Excluding net operating revenues, the Company does not provide guidance on a GAAP basis because it is unable to predict, with reasonable certainty, the future impact of items that are deemed to be outside the control of the Company or otherwise not indicative of its ongoing operating performance. Such items include government, class action, and related settlements; professional fees—accounting, tax, and legal; mark-to-market adjustments for stock appreciation rights; gains or losses related to hedging instruments; loss on early extinguishment of debt; adjustments to its income tax provision (such as valuation allowance adjustments and settlements of income tax claims); items related to corporate and facility restructurings; and certain other items the Company believes to be not indicative of its ongoing operations. These items cannot be reasonably predicted and will depend on several factors, including industry and market conditions, and could be material to the Company's results computed in accordance with GAAP. However, the following reasonably estimable GAAP measures for 2026 would be included in a reconciliation for Adjusted EBITDA if the other reconciling GAAP measures could be reasonably predicted: Interest expense and amortization of debt discounts and fees - approximately $130 million Amortization of debt-related items - approximately $10 million The Q3 Earnings Form 8-K and, when led, the September 2026 Form 10-Q can be found on the Company's website at http://investor.encompasshealth.com and the SEC's website at www.sec.gov.

Encompass Health Corporation and Subsidiaries Condensed Consolidated Statements of Operations (Unaudited)

Net operating revenues Operating expenses: Salaries and benefits Other operating expenses Occupancy costs Supplies General and administrative expenses Depreciation and amortization

Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 (In Millions, Except Per Share Data) $ 1,609.5

$ 1,477.5

$ 4,793.5

$ 4,390.6

840.7 245.2 15.0 65.0 59.9 95.7

784.8 231.1 14.9 64.6 56.1 82.4

2,479.1 742.0 44.9 195.4 180.7 273.4

2,314.8 662.4 44.5 189.9 167.8 241.5

3

Total operating expenses Loss on early extinguishment of debt Interest expense and amortization of debt discounts and fees Other income Equity in net income of nonconsolidated affiliates Income from continuing operations before income tax expense Provision for income tax expense Income from continuing operations (Loss) income from discontinued operations, net of tax

1,321.5 —

1,233.9 —

3,915.5 3.4

3,620.9 —

32.2 (1.9) (0.1) 257.8 53.4 204.4 (0.8) 203.6 (53.7) 149.9

30.8 (5.9) (1.2) 219.9 44.9 175.0 (0.4) 174.6 (48.1) 126.5

96.8 (29.7) (0.6) 808.1 163.4 644.7 14.5 659.2 (160.9) $ 498.3

93.0 (15.1) (3.5) 695.3 137.5 557.8 (1.8) 556.0 (135.9) $ 420.1

100.5 102.3

98.8 100.2

100.5 102.3

Net income

Less: Net income attributable to noncontrolling interests

Net income attributable to Encompass Health

$

Weighted average common shares outstanding:

98.3 99.7

Basic Diluted

Earnings per common share: Basic earnings per share attributable to Encompass Health common shareholders: Continuing operations Discontinued operations Net income

$

Continuing operations Discontinued operations Net income

$

Diluted earnings per share attributable to Encompass Health common shareholders:

Amounts attributable to Encompass Health common shareholders: Income from continuing operations (Loss) income from discontinued operations, net of tax Net income attributable to Encompass Health

$

1.53 (0.01) 1.52

$

1.51 (0.01) $ 1.50

$

$

$

$

$

$

$

150.7 (0.8) 149.9

$

1.26 — 1.26

$

1.24 — 1.24

$

126.9 (0.4) 126.5

$

$

$

$

4.88 0.15 5.03

$

4.83 0.14 4.97

$

483.8 14.5 498.3

$

$

4.19 (0.02) 4.17

4.13 (0.02) $ 4.11

$

421.9 (1.8) 420.1

Encompass Health Corporation and Subsidiaries Condensed Consolidated Balance Sheets (Unaudited)

Current assets:

Assets

Cash and cash equivalents Restricted cash Accounts receivable Other current assets Total current assets Property and equipment, net Operating lease right-of-use assets Goodwill Intangible assets, net Other long-term assets

September 30, December 31, 2026 2025 (In Millions) $

Total assets

$

Current portion of long-term debt Current operating lease liabilities Accounts payable Accrued expenses and other current liabilities Total current liabilities Long-term debt, net of current portion Long-term operating lease liabilities Deferred income tax liabilities Other long-term liabilities

$

Liabilities and Shareholders' Equity Current liabilities:

Total liabilities

Commitments and contingencies Redeemable noncontrolling interests

Shareholders' equity:

Encompass Health shareholders' equity Noncontrolling interests Total shareholders' equity

Total liabilities and shareholders' equity

$

76.2 24.0 712.0 200.8 1,013.0 4,477.6 194.5 1,323.5 301.5 256.4 7,566.5 47.8 28.0 231.4 620.2 927.4 2,551.3 176.3 127.5 222.8 4,005.3

$

$ $

72.2 30.7 619.2 183.8 905.9 4,101.6 212.6 1,317.6 308.3 243.7 7,089.7 43.6 26.5 178.2 588.1 836.4 2,447.2 196.6 126.8 206.9 3,813.9

58.6

58.3

2,681.2 821.4 3,502.6 7,566.5

2,438.2 779.3 3,217.5 7,089.7

$

4

Encompass Health Corporation and Subsidiaries Condensed Consolidated Statements of Cash Flows (Unaudited) Nine Months Ended September 30, 2026 2025 (In Millions)

Cash flows from operating activities:

Net income (Income) loss from discontinued operations, net of tax Adjustments to reconcile net income to net cash provided by operating activities— Depreciation and amortization Loss on early extinguishment of debt Stock-based compensation Deferred tax expense Gain on investments Other, net Change in assets and liabilities, net of acquisitions— Accounts receivable Other assets Accounts payable Accrued payroll Accrued interest payable Other liabilities Net cash provided by (used in) operating activities of discontinued operations Total adjustments

$

659.2 (14.5)

$

556.0 1.8

273.4 3.4 40.3 1.6 (21.8) 9.7

241.5 — 38.1 3.2 (6.1) 7.2

(89.5) (20.8) 43.5 13.6 (5.7) 46.1

(18.8) (19.5) (32.7) 6.4 (15.8) 70.8

19.2 313.0 957.7

(2.5) 271.8 829.6

Purchases of property, equipment, and intangible assets Proceeds from sale of restricted investments Purchases of restricted investments Other, net

(617.2) 83.2 (79.7) (13.6) (627.3)

(507.1) 160.0 (165.9) (12.2) (525.2)

Proceeds from bond issuance Principal payments on debt, including pre-payments Borrowings on revolving credit facility Payments on revolving credit facility Principal payments under finance lease obligations Debt amendment and issuance costs Repurchases of common stock, including fees and expenses Dividends paid on common stock Distributions paid to noncontrolling interests of consolidated affiliates Taxes paid on behalf of employees for shares withheld Other, net

598.8 (414.5) 745.0 (800.0) (19.7) (13.9) (203.7) (57.9) (141.8) (30.9) 5.5 (333.1) (2.7) 102.9 100.2

— (113.2) 140.0 (80.0) (17.7) — (81.7) (52.1) (109.4) (19.9) 0.2 (333.8) (29.4) 123.1 93.7

Net cash provided by operating activities Cash flows from investing activities:

Net cash used in investing activities Cash flows from financing activities:

Net cash used in financing activities Decrease in cash, cash equivalents, and restricted cash Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period

$

$

Encompass Health Corporation and Subsidiaries Supplemental Information Earnings Per Share

Adjusted EBITDA

Depreciation and amortization Interest expense and amortization of debt discounts and fees Stock-based compensation Loss on disposal or impairment of assets

Items not indicative of ongoing operating performance: Loss on early extinguishment of debt

Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 (In Millions, Except Per Share Data) $

346.6 (95.7)

$

300.1 (82.4)

$ 1,043.4 (273.4)

$

932.3 (241.5)

(32.2) (15.0) (0.8) 202.9

(30.8) (14.3) (1.9) 170.7

(96.8) (40.3) (3.2) 629.7

(93.0) (38.1) (2.4) 557.3

—

—

(3.4)

—

5

State regulatory change impact on noncontrolling interests Change in fair market value of marketable securities Gain on sale of Gamma Knife

Pre-tax income

Income tax expense

Income from continuing operations (1)

$

1.5 (0.3) — 204.1 (53.4) 150.7

$

98.3 99.7

Basic shares Diluted shares

Basic earnings per share (1) Diluted earnings per share (1)

$ $

1.53 1.51

— 1.1 — 171.8 (44.9) 126.9

1.5 1.9 17.5 647.2 (163.4) $ 483.8

— 2.1 — 559.4 (137.5) $ 421.9

100.5 102.3

98.8 100.2

100.5 102.3

$ $

1.26 1.24

$ $

4.88 4.83

$ $

4.19 4.13

(1) Income from continuing operations attributable to Encompass Health

Encompass Health Corporation and Subsidiaries Supplemental Information Adjusted Earnings Per Share

Earnings per share, as reported

Adjustments, net of tax: State regulatory change impact Income tax adjustments Loss on early extinguishment of debt Change in fair market value of marketable securities Gain on sale of Gamma Knife

Adjusted earnings per share*

Three Months Ended September 30, 2026 2025

Nine Months Ended September 30, 2026 2025

$

$

$

1.51 0.01 — — — —

1.52

$

$

1.24 — — — (0.01) —

1.23

4.83 0.01 (0.05) 0.02 (0.01) (0.13)

$

4.67

$

$

4.13 — (0.12) — (0.01) —

3.99

Adjusted EPS may not sum due to rounding.

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Net Cash Provided by Operating Activities to Adjusted EBITDA

Net cash provided by operating activities

Interest expense and amortization of debt discounts and fees (Loss) gain on investments, excluding impairments Equity in net income of nonconsolidated affiliates Net income attributable to noncontrolling interests in continuing operations Amortization of debt-related items

Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 (In Millions) $

362.0

$

270.8

$

957.7

$

829.6

32.2 (0.8) 0.1

30.8 3.0 1.2

96.8 21.8 0.6

93.0 6.2 3.5

(53.7) (2.1)

(48.1) (2.4)

(160.9) (6.7)

(135.9) (7.2)

6

Distributions from nonconsolidated affiliates Current portion of income tax expense Change in assets and liabilities Cash used in (provided by) operating activities of discontinued operations State regulatory change impact on noncontrolling interests Change in fair market value of marketable securities Gain on sale of Gamma Knife Other

Adjusted EBITDA

$

(0.1) 57.2 (48.1)

— 47.0 (1.8)

(0.3) 161.8 12.8

(1.4) 134.3 9.6

1.1 (1.5) 0.3 — — 346.6

0.6 — (1.1) — 0.1 300.1

(19.2) (1.5) (1.9) (17.5) (0.1) $ 1,043.4

2.5 — (2.1) — 0.2 932.3

$

$

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

Adjusted EBITDA*

Depreciation and amortization Interest expense and amortization of debt discounts and fees Stock-based compensation Loss on disposal or impairment of assets State regulatory change impact on noncontrolling interests Change in fair market value of marketable securities

Income from continuing operations before income tax expense

Provision for income tax expense

For the Three Months Ended September 30, 2026 Adjustments State Change in Fair Regulatory Market Value As Change of Marketable As Reported Impact Securities Adjusted (In Millions, Except Per Share Amounts) $ 346.6 $ — $ — $ 346.6 (95.7) (32.2) (15.0) (0.8) 1.5 (0.3) 204.1 (53.4)

Income from continuing operations attributable to Encompass Health $ 150.7 $ 1.51 Diluted earnings per share from continuing operations** 99.7 Diluted shares used in calculation

2.9 — — — (1.5) — 1.4 (0.4)

$ $

1.0 0.01

— — — — — 0.3 0.3 (0.1)

$ $

0.2 —

(92.8) (32.2) (15.0) (0.8) — — 205.8 (53.9)

$ 151.9 $ 1.52

  • See reconciliation of net income to Adjusted EBITDA. ** Adjusted EPS may not sum across due to rounding.

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

Adjusted EBITDA*

Depreciation and amortization Interest expense and amortization of debt discounts and fees Stock-based compensation Loss on disposal or impairment of assets

For the Three Months Ended September 30, 2025 Adjustments Change in Fair Market Value As Income Tax of Marketable As Reported Adjustments Securities Adjusted (In Millions, Except Per Share Amounts) $ 300.1 $ — $ — $ 300.1 (82.4) (30.8) (14.3) (1.9)

— — — —

— — — —

(82.4) (30.8) (14.3) (1.9)

7

Change in fair market value of marketable securities

1.1 171.8 (44.9)

Income from continuing operations before income tax expense

Provision for income tax expense

Income from continuing operations attributable to Encompass Health $ 126.9 $ 1.24 Diluted earnings per share from continuing operations** 102.3 Diluted shares used in calculation

— — (0.2)

$ $

(0.2) —

(1.1) (1.1) 0.3

(0.8) $ (0.01) $

$ $

— 170.7 (44.8)

125.9 1.23

  • See reconciliation of net income to Adjusted EBITDA. ** Adjusted EPS may not sum across due to rounding.

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share

As Reported Adjusted EBITDA*

Depreciation and amortization Interest expense and amortization of debt discounts and fees Stock-based compensation Loss on disposal or impairment of assets Loss on early extinguishment of debt State regulatory change impact on noncontrolling interests Change in fair market value of marketable securities Gain on sale of Gamma Knife

Income from continuing operations before income tax expense

Provision for income tax expense

$ 1,043.4

(273.4) (96.8) (40.3) (3.2) (3.4) 1.5 1.9 17.5

For the Nine Months Ended September 30, 2026 Adjustments State Loss on Change in Fair Gain on Regulatory Early Market Value Sale of Change Exting. of Income Tax of Marketable Gamma Impact Debt Adjustments Securities Knife (In Millions, Except Per Share Amounts) $ — $ — $ — $ — $ —

647.2 (163.4)

Income from continuing operations attributable to $ 483.8 Encompass Health Diluted earnings per share from continuing operations** $ 4.83 100.2 Diluted shares used in calculation

$ $

As Adjusted $ 1,043.4

2.9 — — — — (1.5) — —

— — — — 3.4 — — —

— — — — — — — —

— — — — — — (1.9) —

— — — — — — — (17.5)

1.4 (0.4)

3.4 (0.9)

— (5.2)

(1.9) 0.5

(17.5) 4.5

632.6 (164.9)

(1.4) (0.01)

$ (13.0) $ (0.13)

$ 467.7 $ 4.67

1.0 0.01

$ $

2.5 0.02

$ $

(5.2) (0.05)

$ $

  • See reconciliation of net income to Adjusted EBITDA. ** Adjusted EPS may not sum across due to rounding.

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Income from Continuing Operations Attributable to Encompass Health per Diluted Share to Adjusted Earnings Per Share For the Nine Months Ended September 30, 2025 Adjustments 8

(270.5) (96.8) (40.3) (3.2) — — — —

Change in Fair Market Value As Income Tax of Marketable As Reported Adjustments Securities Adjusted (In Millions, Except Per Share Amounts) $ 932.3 $ — $ — $ 932.3

Adjusted EBITDA*

Depreciation and amortization Interest expense and amortization of debt discounts and fees Stock-based compensation Loss on disposal or impairment of assets Change in fair market value of marketable securities

(241.5) (93.0) (38.1) (2.4) 2.1 559.4 (137.5)

Income from continuing operations before income tax expense

Provision for income tax expense

Income from continuing operations attributable to Encompass Health $ 421.9 $ 4.13 Diluted earnings per share from continuing operations** 102.3 Diluted shares used in calculation

— — — — — — (11.8)

$ $

— — — — (2.1) (2.1) 0.6

(11.8) (0.12)

$ $

(1.5) $ (0.01) $

(241.5) (93.0) (38.1) (2.4) — 557.3 (148.7)

408.6 3.99

  • See reconciliation of net income to Adjusted EBITDA. ** Adjusted EPS may not sum across due to rounding.

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Net Income to Adjusted EBITDA Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 (In Millions)

Net income

Loss (income) from discontinued operations, net of tax, attributable to Encompass Health Net income attributable to noncontrolling interests included in continuing operations Provision for income tax expense Interest expense and amortization of debt discounts and fees Depreciation and amortization Loss on early extinguishment of debt Loss on disposal or impairment of assets Stock-based compensation State regulatory change impact on noncontrolling interests Change in fair market value of marketable securities Gain on sale of Gamma Knife

Adjusted EBITDA

$

$

203.6

$

174.6

$

659.2

$

556.0

0.8

0.4

(14.5)

1.8

(53.7) 53.4

(48.1) 44.9

(160.9) 163.4

(135.9) 137.5

32.2 95.7 — 0.8 15.0 (1.5) 0.3 — 346.6

30.8 82.4 — 1.9 14.3 — (1.1) — 300.1

96.8 273.4 3.4 3.2 40.3 (1.5) (1.9) (17.5) $ 1,043.4

93.0 241.5 — 2.4 38.1 — (2.1) — 932.3

$

$

Encompass Health Corporation and Subsidiaries Supplemental Information Reconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow

Net cash provided by operating activities

Impact of discontinued operations Net cash provided by operating activities of continuing operations

Three Months Ended Nine Months Ended September 30, September 30, 2026 2025 2026 2025 (In Millions) $

362.0 1.1 363.1

$

270.8 0.6 271.4

$

957.7 (19.2) 938.5

$

829.6 2.5 832.1

9

Capital expenditures for maintenance Distributions paid to noncontrolling interests of consolidated affiliates

Items not indicative of ongoing operating performance: Transaction costs and related liabilities

Adjusted free cash flow

$

(56.0)

(61.4)

(166.0)

(140.5)

(43.7)

(36.1)

(141.8)

(109.4)

— 263.4

$

0.3 174.2

$

3.5 634.2

$

0.3 582.5

For the three months ended September 30, 2026, net cash used in investing activities was $241.6 million and resulted primarily from capital expenditures. Net cash used in nancing activities during the three months ended September 30, 2026 was $153.7 million and resulted primarily from repurchases of common stock, distributions paid to noncontrolling interests of consolidated a liates, net debt payments, and cash dividends paid on common stock. For the three months ended September 30, 2025, net cash used in investing activities was $201.3 million and resulted primarily from capital expenditures. Net cash used in nancing activities during the three months ended September 30, 2025 was $113.2 million and resulted primarily from distributions paid to noncontrolling interests of consolidated a liates, net debt payments, repurchases of common stock, and cash dividends paid on common stock. For the nine months ended September 30, 2026 net cash used in investing activities was $627.3 million and resulted primarily from capital expenditures. Net cash used in nancing activities during the nine months ended September 30, 2026 was $333.1 million and resulted primarily from repurchases of common stock, distributions paid to noncontrolling interests of consolidated a liates, cash dividends paid on common stock, and taxes paid on behalf of employees for shares withheld partially o set by net debt borrowings. For the nine months ended September 30, 2025, net cash used in investing activities was $525.2 million and resulted primarily from capital expenditures. Net cash used in nancing activities during the nine months ended September 30, 2025 was $333.8 million and resulted primarily from distributions paid to noncontrolling interests of consolidated a liates, repurchases of common stock, net debt payments, and cash dividends paid on common stock.

Encompass Health Corporation and Subsidiaries Forward-Looking Statements Statements contained in this press release and the supplemental information which are not historical facts, such as those relating to the business, strategy, outlook, growth targets and guidance considerations, dividend strategies, e ective income tax rates, cost trends, legislative and regulatory developments or their impacts, nancial guidance, ability to return value to shareholders, projected capital expenditures, acquisition opportunities, development projects, addressable market size, other balance sheet and cash ow plans, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may di er materially from those anticipated in these forward-looking statements as a result of a variety of factors. 10

While it is impossible to identify all such factors, factors which could cause actual events or results to di er materially from those estimated by Encompass Health include, but are not limited to, possible reductions or other changes in Medicaid reimbursement, including Medicaid directed and supplemental payment programs and Medicaid waiver programs, which may decrease our revenues and increase our provider tax expenses; infectious disease outbreak, including the speed, depth, geographic reach and duration of its spread, which could decrease our patient volumes and revenues and lead to sta ng and supply shortages and associated cost increases; Encompass Health's infectious disease prevention and control e orts; the demand for Encompass Health's services, including based on any downturns in the economy and consumer con dence in patient care; the price of Encompass Health's common stock as it a ects Encompass Health's willingness and ability to repurchase shares and the nancial and accounting e ects of any repurchases; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, in acquired operations; Encompass Health's ability to attract and retain key management personnel; potential disruptions, breaches, or other incidents a ecting the proper operation, availability, or security of Encompass Health's or its vendors' or partners' information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; Encompass Health's ability to successfully complete and integrate de novo developments, acquisitions, investments, and joint ventures consistent with its growth strategy; increases in Medicare audit activity, including increased use of sampling and extrapolation, resulting in additional unpaid reimbursement claims and an increase in the backlog of appealed claims denials; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels, including as part of national healthcare reform and de cit reduction and Encompass Health's ability to adapt operations to those changes, including in connection with the CMS inpatient rehabilitation review choice demonstration project; competitive pressures in the healthcare industry and Encompass Health's response thereto; Encompass Health's ability to obtain and retain favorable arrangements with third-party payors; Encompass Health's ability to control costs, particularly labor and employee bene t costs, including group medical expenses; adverse e ects resulting from coverage determinations made by Medicare Administrative Contractors regarding its Medicare reimbursement claims and lengthening delays in Encompass Health's ability to recover improperly denied claims through the administrative appeals process on a timely basis, including as part of the review choice demonstration; Encompass Health's ability to adapt to changes in the healthcare delivery system, including value-based purchasing such as the transforming episode accountability model and involvement in coordinated care initiatives or programs that may arise with its referral sources; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe sta ng shortages, which may be worsened by infectious disease outbreaks, and the impact on Encompass Health's labor expenses from potential union activity, sta ng shortages, and competitive compensation practices; general conditions in the economy and capital markets, including any instability or uncertainty related to trade war, armed con ict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; the increase in the cost of, or the decrease in the availability of, construction materials and necessary supplies, including as a result of tari s and import restrictions; the increase in the costs of defending and insuring against alleged professional liability claims, and Encompass Health's ability to predict the estimated costs related to such claims; and other factors which may be identi ed from time to time in Encompass Health's SEC lings and other public 11

announcements, including Encompass Health's Form 10‑K for the year ended December 31, 2025 and Form 10-Q for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026, when led. Media Contact Polly Manuel, 205 969-4532 [email protected] Investor Relations Contact Mark Miller, 205 970-5860 [email protected] View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-healthreports-results-for-third-quarter-2026-302922661.html SOURCE Encompass Health Corp.

12

Prompts

Encompass Health Corporation (ticker EHC), listed in United States.

Company History

Date Change Detail
Jan 3, 2018 Renamed HEALTHSOUTH CORP → ENCOMPASS HEALTH CORP

ETFs Holding Encompass Health Corporation

ETF Weight in ETF Shares Market value As of
GLRY 2.67% 36,720 $ 4.414M Aug 31, 2026
PJFM 2.60% 3,739 $ 515.533K Nov 18, 2026
OSCV 2.13% 135,598 $ 15.061M Jul 31, 2026
FTKI 2.01% 3,595 $ 510.885K Nov 16, 2026
JPSV 1.52% 3,123 $ 430.599K Nov 17, 2026
HSMV 1.20% 465 $ 66.081K Nov 16, 2026
SMDX 0.83% 7,363 $ 1.046M Nov 17, 2026
MCDS 0.73% 415 $ 57.22K Nov 17, 2026
LRGC 0.56% 62,970 $ 7.57M Aug 31, 2026
VFMV 0.50% 18,863 $ 2.268M Aug 31, 2026
TMSL 0.47% 126,853 $ 12.822M Jun 30, 2026
SIXL 0.47% 6,982 $ 983.275K Nov 12, 2026
JMEE 0.41% 83,958 $ 11.576M Nov 17, 2026
AVMV 0.39% 23,026 $ 3.272M Nov 16, 2026
FTHI 0.34% 59,634 $ 8.475M Nov 16, 2026
DFAS 0.23% 555,369 $ 78.213M Nov 12, 2026
AVLV 0.23% 369,376 $ 52.492M Nov 16, 2026
MSSM 0.22% 13,131 $ 1.578M Aug 31, 2026
AVMC 0.17% 6,650 $ 945.032K Nov 16, 2026
SYZ 0.16% 1,057 $ 106.842K Jun 30, 2026
AVUQ 0.14% 4,285 $ 608.941K Nov 16, 2026
ESUM 0.14% 2,294 $ 254.795K Jul 31, 2026
FTLS 0.10% 18,593 $ 0.00 Nov 16, 2026
DXUV 0.09% 39,738 $ 5.596M Nov 12, 2026
AVSU 0.08% 2,774 $ 394.213K Nov 16, 2026
DFUV 0.08% 84,060 $ 11.838M Nov 12, 2026
AVUS 0.07% 67,871 $ 9.645M Nov 16, 2026
AVLC 0.07% 7,375 $ 1.048M Nov 16, 2026
DFAC 0.07% 420,955 $ 59.283M Nov 12, 2026
DCOR 0.05% 171,436 $ 24.143M Nov 12, 2026
EBI 0.05% 2,990 $ 359.428K Aug 31, 2026
DFAU 0.03% 25,692 $ 3.618M Nov 12, 2026
MKTN short -0.03% -265 $ -26.786K Jun 30, 2026
DFUS 0.02% 33,824 $ 4.763M Nov 12, 2026
VSLU 0.02% 993 $ 100.372K Jun 30, 2026
MSLC 0.01% 3,874 $ 465.694K Aug 31, 2026